DeepMed Research

WILLIAM BEAUMONT HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1955-01-01

Employees: -

Market Cap: -

Website: http://www.beaumont.edu/patients-visitors/locations-maps-and-directions/beaumont-royal-oak-campus/

Clinical Trials

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder

Not Applicable

Recruiting

Conditions: Overactive Bladder
Urinary Frequency
Overactive Bladder Syndrome
Urinary Urgency

Interventions: Device: Sham BTL Emsella Chair
Device: BTL Emsella Chair

First Posted Date: 2021-05-05

Last Posted Date: 2023-11-08

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 166

Registration Number: NCT04873037

Locations: 🇺🇸
Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

Completed

Conditions: Covid19

First Posted Date: 2021-04-02

Last Posted Date: 2021-04-02

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 704

Registration Number: NCT04829552

Locations: 🇺🇸
Beaumont Health System (BHS), Royal Oak, Michigan, United States

Nasal Suction in Infants With Bronchiolitis Using a NoseFrida vs. Bulb Syringe

Not Applicable

Terminated

Conditions: Respiratory Disease
Bronchiolitis

Interventions: Device: Bulb syringe nasal suction device
Device: Nose Frida nasal suction device

First Posted Date: 2020-10-22

Last Posted Date: 2024-04-04

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 21

Registration Number: NCT04599101

Locations: 🇺🇸
Margaret J Menoch, MD, Royal Oak, Michigan, United States

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Phase 2

Terminated

Conditions: COVID-19
Severe Acute Respiratory Syndrome (SARS)
Coronavirus Infections

Interventions: Biological: COVID-19 convalescent plasma

First Posted Date: 2020-06-16

Last Posted Date: 2022-03-09

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 71

Registration Number: NCT04432272

Locations: 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States

Blood Sampling Functionality of Extended Dwell Catheters

Not Applicable

Completed

Conditions: Vascular Access Complication
Peripheral Venous Access
IV Catheter-Related Infection or Complication

Interventions: Device: Extended dwell catheters

First Posted Date: 2020-06-01

Last Posted Date: 2024-11-15

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 100

Registration Number: NCT04409418

Locations: 🇺🇸
Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States

Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness

Not Applicable

Completed

Conditions: Bronchiolitis Acute
Respiratory Disease
Asthma in Children
Pneumonia in Children

Interventions: Device: Intermittent Pulse oximeter
Device: Continous Pulse oximeter

First Posted Date: 2020-05-29

Last Posted Date: 2022-03-10

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 6

Registration Number: NCT04407806

Locations: 🇺🇸
Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States

Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation

Not Applicable

Completed

Conditions: Cardiac Catheterization
Radiation Exposure

Interventions: Radiation: Without ControlRad System
Radiation: ControlRad System

First Posted Date: 2020-05-27

Last Posted Date: 2023-01-11

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 170

Registration Number: NCT04404257

Locations: 🇺🇸
Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

Phase 2

Terminated

Conditions: Acute Respiratory Distress Syndrome
Severe Acute Respiratory Syndrome (SARS)
COVID-19
Coronavirus Infections

Interventions: Other: Placebo
Drug: Naltrexone
Drug: Ketamine

First Posted Date: 2020-04-28

Last Posted Date: 2022-01-26

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 70

Registration Number: NCT04365985

Locations: 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States

Beaumont Health Large-scale Automated Serologic Testing for COVID-19

Completed

Conditions: Coronavirus Infection
COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2

Interventions: Diagnostic Test: EUROIMMUN assay

First Posted Date: 2020-04-16

Last Posted Date: 2021-09-05

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 20614

Registration Number: NCT04349202

Locations: 🇺🇸
Beaumont Health System, Royal Oak, Michigan, United States
🇺🇸
Beaumont Health, Royal Oak, Michigan, United States

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

Terminated

Conditions: COVID-19
SARS-COV2
Severe Acute Respiratory Syndrome

Interventions: Device: CT-V

First Posted Date: 2020-03-25

Last Posted Date: 2022-01-05

Lead Sponsor: William Beaumont Hospitals

Target Recruit Count: 15

Registration Number: NCT04320511

Locations: 🇺🇸
Beaumont Health, Royal Oak, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy